Animals and husbandry
Wild-type C57Bl6N mice were obtained from Janvier (Le Genest-Saint-Isle, France) and kept at the animal husbandry facilities of the Universities of Freiburg or Strasbourg. SOM-Cre (SST tm2.1(cre)Zjh/J) mice were provided by the Department of Biomedicine Basel and SOM-IRS-Cre/J from the Department of Physiology of the University of Freiburg and kept at the animal husbandry facility of the University of Freiburg. Adult animals (10-14 weeks) were used for all experiments. All procedures were previously approved by animal review boards in Germany (Regierungspräsidium Freiburg) or France (CREMEAS); the animal care use protocols followed national and international standards and were systematically documented. Prior power calculations for behavioral assessments were performed to reduce the number of experimental animals whenever possible.
Electrophysiology
Mice were preoxygenated in a 100% oxygen atmosphere for 5 min before cervical dislocation and decapitated according to national and institutional guidelines. Three hundred micrometer-thick transverse slices from the hippocampus were cut with a vibratome (VT1200, Leica Biosystems, Germany). Slices were prepared in artificial cerebrospinal fluid (aCSF) containing (in mM) 125 NaCl, 25 NaHCO3, 1.25 NaH2PO4, 2.5 KCl, 1 MgCl2, 27 glucose, and 2 CaCl2 (bubbled with carbogen (95% O2, 5% CO2)).
After 20 min of rest at 35 °C, the slices were kept at room temperature in aCSF, transferred to the recording chamber (volume of approximately 2-3 ml) and continuously superfused with aCSF (rate of approximately 5-10 ml/min-1). Differential interference contrast video microscopy (Zeiss Axioskop 2 FS plus, Zeiss Microscopy, Germany) was used to assess the location and morphology of CA1 pyramidal neurons. In addition to optical identification, neurons were classified according to their characteristic firing frequency adaptation to long depolarizing current pulses. Borosilicate glass tubes (2.0 mm outer diameter, 0.5 mm wall thickness; Hilgenberg, Germany) were used to pull the patch pipettes. The pipettes had an open resistance of 5-10 MΩ, and the series resistance (Rs) of 10-50 MΩ was compensated by a bridge balance. The patch pipettes were filled with two different internal solutions for current clamp (EPSP) and voltage clamp (current) measurements. The internal solution for the current clamp contained (in mM) 132 K-gluconate, 20 KCl, 2 MgCl2, 10 HEPES, 0.1 EGTA, 4 Na2ATP, and 0.3 NaGTP (pH adjusted to 7.2 with KOH). The internal solution for voltage clamp measurements contained 135 Cs-gluconate, 2 CsCl, 5 QX314, 10 HEPES, 10 EGTA, 2 MgCl2, 2 Na2ATP, and 2 TEA-Cl (pH adjusted to 7.2 with HCl). Osmolarity (280-300 mosmol/l) was controlled at the beginning of each experimental day with an osmometer (Osmomat, Gonotec, Germany).
A stimulation pipette (a patch pipette with an open resistance of 1-3 MΩ when filled with internal solution) was placed superficially in the stratum radiatum of the CA1 region approximately 30-50 µm from the PC layer. Subthreshold EPSPs (for LTP protocols and wash-in experiments: 2-7 mV; for the microcircuit-activating (MICA) protocol: 5-10 mV) were evoked by Schaffer collateral stimulation with voltage pulses of 10-80 V (frequency of 0.1 Hz, duration of 200 µs) using a stimulus isolator (Model 2100 isolated pulse stimulator, A-M Systems, USA). The resting membrane potentials were between -75 and -65 mV, and the holding potential was -70 mV for PCs and between -60 mV and -65 mV for interneurons, with a holding potential of -60 mV. Hyperpolarizing voltage test pulses (50 ms/-5 mV) were applied to assess the input (Rm) and series (Rs) resistance after every 10th EPSP. For aLTP and weak aLTP, EPSPs were combined with postsynaptic action potentials (APs) triggered by short (3 ms) 700 pA current injections via a patch-clamp electrode. EPC-10 amplifiers (HEKA, Germany) were used, and the signals were filtered at 5 kHz. Patchmaster NEXT software (version 1.2, HEKA, Germany) was used for data acquisition and initial analysis. All experiments were performed at room temperature.
Experiments were discarded if (i) Rs changed by more than 30% during the experiment, (ii) evidence of ictal discharges was observed, (iii) the membrane potential between the start and end of the experiment differed by more than 5 mV, or (iv) the neurons did not respond to a firing pattern control pulse at the beginning and end of the experiments. Two experienced raters who were blinded to the experimental group agreed to the exclusion of the experiments. The experiments were performed in parallel; the experimenters were blinded to the treatment groups. A maximum of two hippocampal slices per animal were used. All groups included at least 6 animals with equal sex ratios.
Identification of SOM-Ins: Slices from mice expressing tdTomato in SOM-INs (SOM-Cre (SST tm2.1(cre)Zjh/J)) or from wild-type mice were prepared as described above. Interneurons were visually identified by fluorescence imaging at an excitation wavelength of 553 nm and an emission wavelength of 580 nm by using a polychromator (Polychrome IV, Till Photonics, Germany), a fluorescence camera (Orca Flash 4.0, Hamamatsu, Japan) and the SmartLUX extension for Patchmaster NEXT software (HEKA, Germany). In slices from wild-type animals, SOM-INs were identified by their morphological characteristics, their location in the stratum oriens, and an initial membrane potential in the range of -60 mV.
aLTP: Five EPSPs and five postsynaptic APs were paired at 100 Hz with a 5 ms delay (AP after EPSP). Five of these bursts of synchronized EPSP→AP pairs were applied at theta frequency (5 Hz), followed by an interval of 10 s and 4 more theta blocks, resulting in 125 EPSP/AP pairings.
Weak-aLTP: Unlike aLTP, only one theta block was applied, resulting in 25 EPSP/AP pairings.
Wash-in experiments: EPSPs were elicited by Schaffer collateral stimulation at a frequency of 0.1 Hz. The mean baseline EPSP amplitude was calculated at 0-5 min. Substances were continuously applied to the bath solution after baseline recording for an additional 30 min. Mean EPSP amplitudes were calculated between 25 and 30 min after wash-in.
Voltage-clamp recordings of NMDAR currents: At a holding potential of -70 mV (PCs) or -60 mV (SOM-INs), the cells were depolarized to +40 mV for 1 s. Five hundred milliseconds after the beginning of depolarization, extracellular stimulation was applied by Schaffer collateral stimulation (PCs) or by extracellular stimulation (≤ 10 V) in the stratum oriens at a distance of approximately 200 µm from the clamped interneuron (SOM-IN). Ten peak current amplitudes with an interval of 30 s were averaged before and after the bath application of substances.
MICA: A 300 ms depolarizing current between +100 and +600 pA was injected via the patch pipette into a PC to elicit a train of 5-10 APs. After an interval of 600 ms, one EPSP (5-10 mV amplitude) was elicited by Schaffer collateral stimulation. This pattern was continuously repeated at a frequency of 0.2 Hz. Substances were added by bath application after a stable 10 min baseline recording for an additional 20 min.
siRNA
Two hours after the induction phase of the CDM protocol, the animals were anesthetized with isoflurane and placed on a heating pad. The lower back was shaved and disinfected, and the siRNA compound was slowly injected into the space between the L5 and L6 vertebrae. In some preparatory experiments, ink was injected to confirm the accuracy and reliability of the intrathecal injection technique (Supplementary Fig. 5a). The siRNA mixture contained (per animal) 0.06 μl in vivo-jetPEI solution (Polyplus-transfection, France), 50 nM siRNA, 5 μl glucose solution (10%) and 4.94 μl H2O, as described in a recently established protocol79. Afterward, the animals were allowed to rest for three days in their cages before the outcomes were assessed. The details of the siRNAs used were as follows: Ambion In Vivo Ready, HPLC-IVR (Thermo Fisher Scientific, s201423, catalog # 4457310); chromosome location: Chr. 7: 45831883-45872689 on GRCm38; RefSeq: NM_008172.2; translated protein: NP_032198.2; target exons: 2 and 3; and siRNA location: 1197. For the control experiments shown in Fig. 4d and Fig. 6 (scrambled siRNA), we used Ambion In Vivo Negative Control #1 siRNA (Thermo Fisher Scientific, catalog # 4457289). In all other siRNA experiments, the control group received the treatment described above, but the siRNA was omitted.
DREADD and stereotactic surgery
Prior to surgery, 4 mg/kg carprofen and 0.1 mg/kg buprenorphine were injected subcutaneously. Mice were anesthetized with isoflurane (4% for sedation induction, 1.5% for maintenance) and placed on a stereotactic frame (51730UD, Stoelting, USA). Body temperature was maintained using a heating pad. A total of 300 nL of a viral suspension of either pAAV2/5-hSyn-DIO-hM4D(Gi)-mCherry (44362-AAV5, Addgene, USA) or pAAV2/5-hSyn-DIO-hM3D(Gq)-mCherry (44361-AAV5, Addgene, USA) was injected bilaterally into the hippocampus (-1.7 AP, +/-0.65 ML, -1.6 DV) of SOM-IRS-Cre/J mice using a 30G syringe (Hamilton Neuros syringe) and a microinjection syringe pump (UMP3T, WPI, USA) at a rate of 200 nL/min. After injection, the syringe was left in place for five minutes before removal. After surgery, the mice received 0.1 mg/kg buprenorphine subcutaneously and 0.06 mg/100 ml buprenorphine in the drinking water overnight. The mice were then allowed to rest for 3 weeks before further experimental procedures.
Immunohistochemistry
Brains were extracted after the intracardiac perfusion of mice with 20 mL of ice-cold phosphate-buffered saline (PBS; 8.1 mM Na2HPO4, 138 mM NaCl, 2.7 mM KCl and 1.47 mM KH2PO4 [pH 7.4]), followed by 15 mL of 4% paraformaldehyde (PFA) in PBS solution. The brains were postfixed in 4% PFA/PBS for 6 hours at 4 °C and then cryoprotected for 48 hours in a 30% sucrose/PBS solution at 4 °C. After sectioning with a cryostat, 30 μm-thick sections of the hippocampus were washed and blocked with 4% normal goat serum in PBS for 1 hour at room temperature. The primary antibodies were diluted in PBS, 0.3% Triton X-100, and 1% goat serum and incubated overnight at 4 °C under agitation. The sections were then washed three times for five minutes in PBS supplemented with 1% Triton X-100 and incubated for one hour at room temperature with secondary antibodies diluted in PBS supplemented with 1% Triton X-100 and 1% goat serum. The sections were then incubated for 15 minutes at room temperature with nuclear 1 mg/mL 4,6-diamidino-2-phenylindole (DAPI, Thermo Fisher Scientific, USA, 1:1000) in PBS containing 0.2% Triton. After washing, the sections were mounted with Mowiol-DABCO (803456, Merck, Germany).
The following primary antibodies were used: guinea pig polyclonal anti-VGLUT1 (AB5905, 1:5000; Millipore, USA, lot #3878831) and mouse anti-GAD65 (ab26113, 1:500, Abcam, United Kingdom, lot #GR3308495-2). The following secondary antibodies were used: goat polyclonal anti-guinea pig Alexa Fluor 594 (Invitrogen, USA, A-11076, 2 μg/mL, lot #2540867) and goat polyclonal anti-mouse Alexa Fluor 488 (Invitrogen, USA, A-32723, 2 μg/mL; lot #XA336883). All images were taken using a Zeiss Celldiscoverer 7 microscope equipped with a confocal LSM 900 with AiryScan 2. The objective used was a Plan-Apochromat 50 x/1.2 W, N. A 1.2, H²O immersion. The laser intensity and gain were set to occupy the full dynamic range of the detector.
GluN2D immunoblotting: Hippocampal tissue was dissociated in ice-cold RIPA buffer (30 mM Tris base (pH 7.4), 150 mM NaCl, and 1% Triton X-100) containing protease and phosphatase inhibitors. Debris was removed by centrifugation (13,000 × g at 4 °C, 15 min). Protein quantification was performed by the BCA method. Proteins (50 μg) were resolved on a 10% polyacrylamide gel under denaturing conditions and transferred onto a polyvinylidene difluoride membrane. The membranes were blocked with Tris-buffered saline (10 mM Tris and 200 mM NaCl, pH 7.4) containing 5% nonfat dry milk. The blots were incubated overnight with GluN2D primary antibody from Millipore Sigma (Germany, MAB5578, lot #3352415; 1:500). After incubation with the appropriate IRDye 800 CW-conjugated anti-rabbit secondary antibody, the proteins were visualized with an Odyssey Imaging System (LI-COR Biotechnology, USA). Tubulin (Abcam, United Kingdom, ab11321; 1:15 000) was used as a loading control, and ImageJ (https://imagej.nih.gov/ij/, NIH, USA) was used to calculate the relative density of the bands.
PSD95 and GluA1 immunoblotting: Dissected brain regions or whole acute slices were mechanically homogenized in either homogenization buffer (320 mM sucrose, 4 mM HEPES [pH 7.4], 2 mM EDTA) or immunoprecipitation (IP) buffer (50 mM Tris HCl [pH 7.4], 120 mM NaCl, 5 mM EDTA, 0.5% Triton X-100) and centrifuged at 800 × g for 10 min at 4 °C to generate total (S1) and nuclear fractions (P1). All buffers contained a phosphatase and protease inhibitor cocktail (Sigma‒Aldrich, USA). Synaptic (P2) and cytosolic (S2) fractions were obtained by centrifugation of S1 at 10 000 × g for 20 min at 4 °C. Washed synaptosomal pellets (P2) were either processed for PSD isolation or directly lysed in lysis buffer (50 mM Tris-HCl [pH 6.8], 1.3% SDS, 6.5%, glycerol, 100 μM sodium orthovanadate) containing phosphatase and protease inhibitor cocktail (Sigma‒Aldrich, USA), boiled for 10 min at 95 °C and processed for SDS‒PAGE and Western blotting. For PSD isolation, P2 was resuspended in 4 mM HEPES [pH 7.4] and 2 mM EDTA, incubated for 30 min at 4 °C and centrifuged at 25 000 × g for 20 min at 4 °C. The obtained pellets were resuspended in homogenization buffer, placed on top of a sucrose gradient (0.8 M, 1.0 M and 1.2 M sucrose with 4 mM HEPES [pH 7.4] and 2 mM EDTA) and centrifuged at 150 000 × g for 2 h at 4 °C. The fraction collected at the interface between 1.0 M and 1.2 M was pelleted by centrifugation at 150 000 × g for 30 min at 4 °C, lysed in lysis buffer and processed for SDS‒PAGE and Western blotting. The protein concentrations of the different fractions were determined using a BCA assay kit (Thermo Fisher Scientific, USA) according to the manufacturer’s instructions. DTT (10 mM) and bromophenol blue were added to total (S1, mixed 1:1 with lysis buffer) or synaptosomal (P2) lysates, boiled for 10 min at 95 °C, separated by SDS‒PAGE on 7.5%-12% acrylamide gels and transferred to polyvinylidene difluoride (PVDF) membranes (Merck Millipore, USA). The membranes were blocked with 5% nonfat dry milk in TBS-T (1% Tween 20 in Tris-buffered saline (TBS)) or Roti-Block (Carl Roth, Germany) and then incubated with the following primary antibodies diluted in TBS: mouse anti-GluA1-NT (Millipore, USA, MAB2263, 1:2000, #3847897), rabbit anti-PSD95 (Cell Signaling, USA, 2507, 1:2000, lot #4), and mouse anti-GAPDH (Abcam, United Kingdom, ab8245, 1:1000, lot #1035914-6). After three washes, the membranes were incubated with the following horseradish peroxidase-conjugated secondary antibodies diluted in TBS-T: sheep anti-mouse (GE Healthcare, USA, NA931, 1:20000, lot #17556470) and donkey anti-rabbit (GE Healthcare, USA, NA9340, 1:25000) for 1 h at room temperature. In some experiments, the membrane was washed and stripped for further reincubation with another antibody. In that case, the membrane was incubated two times for 15 min in a glycin stripping solution (glycin 15g, SDS 1g, Tween20 10mL, 800mL dionized water), washed three times ten minutes in TBS-T, and then blocked and incubated following the regular procedure. The washed membranes were developed with a ChemiDoc MP imaging system (Bio-Rad) using an enhanced chemiluminescence detection kit (Thermo Fisher Scientific, USA). Band intensity was quantified by densitometry with ImageJ 1.47v software (National Institute of Health, USA) and normalized to the appropriate loading control.
Real-time PCR
RNA was isolated from powdered frozen hippocampal samples using a NucleoSpin RNA kit (Macherey Nagel, Germany), and cDNA was prepared using Oligo d(T) primers and Ready-To-Go You-Prime First-Strand Beads (GE Healthcare, Germany). Real-time PCR was performed using a Takyon No Rox SYBR MasterMix dTTP Blue Kit (Eurogentec, Belgium) and a LightCycler 480 (Roche, Switzerland). The reference genes glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 40S ribosomal protein S18 (RPS18) were used as internal controls. The following primer pairs (sequences provided as 5′-3′) were used:
GluN2D (fwd: CTGTGTGGGTGATGATGTTCGT, rev: GTGAAGGTAGAGCCTCCGGG);
GAPDH (fwd: ACAACTTTGGTATCGTGGAAGG, rev: GCCATCACGCCACAGTTTC); RPS18 (fwd: GCGGCGGAAAATAGCCTTTG, rev: GATCACACGTTCCACCTCATC).
Amplification was performed with an initial denaturation of 45 cycles of 95 °C for 10 s, followed by 45 cycles of 60 °C for 15 s and 72 °C for 15 s. A melting curve was obtained at the end of cycling to verify the amplification of a single PCR product. The expression of the GRIN2D/GluN2D gene relative to a normalization factor (the geometric mean of the levels of two reference genes) was calculated using the 2−ΔCt method as previously described80.
Behavioral procedures
Prior to all behavioral experiments, the mice were handled daily for 1 min over a time course of 5 days. Tunnel handling was used for all animal placement.
Chronic Despair Model (CDM): Mice were forced to swim in a glass cylinder (Ø 26 cm, 60 cm high) filled to a depth of 25 cm with 25 °C water for 10 min on 5 consecutive days. The immobility time was measured in each session. After swimming, the animals were gently dried and kept in a cage under a heating light for an additional ten minutes. Afterward, the mice were allowed to rest for two days in their home cages. Mice were treated after the resting period depending on the experimental group. For the measurement of escape behavior, an additional swim session was performed. For intraperitoneal injections, (±)-ketamine was diluted in NaCl (0.9%) and NAB-14 was dissolved in PEG 400 (40%), dimethylacetazolamide (10%) and 50% glucose (5%). Lorazepam was purchased as an injection solution (Tavor Pro injection, 2 mg, Pfizer, Germany). A maximum volume of 0.2 ml was injected per mouse; the volume was individually adjusted to the weight of the animal to achieve the intended dose. As a control, the respective vehicle was administered.
Behavioral readout: After the intervention, the animals were either subjected to an additional swim session (test day) to measure immobility time or subjected to the nosepoke sucrose preference test (NP-SPT) using the IntelliCage system (TSE Systems, Germany). For assessment of immobility time, the mice were videotaped, and two independent experienced raters who were blinded to the experimental groupings analyzed the videos. The mean values determined by both raters were used for further analysis. Immobility time was defined as the cumulative time that the animals remained stationary, during which only movements of the tail or forepaws necessary to keep the head above the water surface were made, the animals did not travel any distance and merely passively floated, no directed movement of the front paws was observed, and the body was mostly oriented parallel to the walls of the cylinder. A detailed description of this protocol and its analysis can be found here45.
Nose-poke sucrose preference test (SPT): The IntelliCage system (TSE Systems, Germany), which allows automatic analysis of the spontaneous and exploratory behavior and drinking preference of rodents, was used. Radiofrequency identification transponders were implanted in the mice. IntelliCage comprises a common space in the middle and four measuring corners. Up to 16 group-housed mice can be given free access to food in the center, while water is supplied in the corners (by two zipper bottles each) behind electronically managed doors. The corners can be visited by only one mouse at a time. Using IntelliCage Plus software, the system records i) the number and duration of corner visits, ii) the number of nosepokes (approaches) on the doors, and iii) the number of licks on the drinking bottles. Initially, the mice were adapted to the IntelliCage for five days and provided free access to food and water in all corners. Then, for three days, the animals were habituated to sucrose (each corner contained one bottle with 1% sucrose solution and one with water; the contents of all bottles were exchanged every day) and subjected to the nosepoke protocol. The mice had to perform a nosepoke to open the doors and access both water and sucrose. Next, an NP-SPT paradigm48 in which gradually increasing effort (number of nosepokes) was needed to access the sucrose-containing bottles for a short period (24 h) was used for the measurement of sucrose preference. In this protocol, each door opened in response to a nosepoke and closed after the animals drank from the sucrose-containing bottle for 5 s, while the mice were allowed to consume water from the water-filled bottles for an unlimited amount of time. The number of nosepokes needed to access the sucrose-containing bottle progressively increased (1, 2, 3, 4, 5, 6, 7) after each of the 10 licking sessions. This test was used to assess the drive for obtaining a reward; a decreased sucrose preference indicates reduced reward behavior. For every side, the number of licks was measured, and the mean sucrose preference was calculated as the percentage of the licks of the sucrose solution-containing bottles compared to the total number of licks. “post 1” and “post 2” represent two consecutive 24 h test periods.
Open field test (OFT): The test was performed in a square arena (50 × 50 cm) surrounded by a 35 cm high wall made of gray PVC. The mice were placed in the center of the field and allowed to move freely. The mice were video tracked for 10 min, and the time spent in the center (16% of the entire area of the box) was compared to the time spent outside the center (time in the center/time outside the center). Tracking and analysis were performed with EthoVision XT software (Noldus, Netherlands).
Object location memory task (OLT): For habituation, the mice were placed in the center of an empty square arena (50 × 50 cm) surrounded by a 35 cm high wall of the gray PVC and maintained there for 10 min. On the following day, the mice were placed in the empty arena for 10 min for a second habituation phase. Immediately thereafter, the mice were removed, and two slightly different objects were introduced into the arena (for location, see Fig. 7a). The animals were then placed back into the area and allowed to rest there for 10 min. Directly after the exploration of the two objects, the mice were injected (KET/NAB-14/saline) and placed back into their home cages. Six hours later, the mice were placed in the arena where the location of one of the two objects was changed (see Fig. 7a for the location of the object) and remained there for another 10 min. During all the time in the arena, the mice were video tracked using EthoVision XT software (Noldus, Netherlands).
Rotarod: A ROTA ROD LE8205 (PanLab, Harvard Apparatus, Spain) was used for the experiments. This instrument automatically detects the latency to fall and enables simultaneous assessment of up to five animals. Before testing, the animals were exposed to three training sessions at 5 rpm for 1-3 min with a 10 min interval between each session. Animals that did not stay on the rod rotating at 5 rpm for at least 60 sec in the third training session were excluded from further testing. For testing, the animals were set on a rod at 4 rpm. The rod was set to accelerate from 4 to 40 rpm in 300 sec, and the latency to fall was measured. This procedure was repeated at 5, 20, 30 and 50 min postinjection, and mean values were calculated for each treatment condition.
Locomotion: The test was performed in a square arena (50 × 50 cm) surrounded by a 35 cm high wall made of gray PVC. The mice were placed in the center of the field and allowed to move freely. Behavior was recorded for 10 min, and the total distance traveled was analyzed with EthoVision XT software (Noldus, Netherlands).
Quantification and statistical analysis
All given values are the mean ± SEM, and the error bars represent the SEMs in the figures; n represents the number of experiments. For the statistical analyses, GraphPad Prism version 8.3.0 (GraphPad Software, USA) was used. To test for significance within experimental groups (e.g., baseline vs. effect), we used a paired t test or a Wilcoxon signed rank test. To compare two experimental groups, either an unpaired t test or the Mann–Whitney test was performed. To compare several time points in one experimental series, repeated-measures ANOVA followed by Dunnett’s correction was used. To test for differences among several treatment groups, ordinary one-way ANOVA followed by Dunnett correction was used. To test for differences between groups with two variables, repeated-measures ANOVA within factors was conducted, and for estimation of effect sizes, ETA squared values were calculated. In cases of sphericity violation, Greenhouse‒Geisser adjustment was applied. Outliers were excluded using ROUT methods set at 1%. All the statistical tests were two-tailed, if applicable. Significance levels are depicted by asterisks in the figures: *p<0.05, **p<0.01, ***p<0.001, ****p<0.001. The exact p and F values as well as the applied tests for each group are listed in Supplementary Table 1.
Sex aspects
All experiments were performed with an equal distribution of male and female mice. For all experiments, a separate exploratory analysis focusing on the potential effects of sex on the experiments was performed, but no relevant differences were observed.
Molecular modeling
The Schrödinger Software Suite 2021-4 (Schrödinger LLC, NY, USA) was used for modeling studies. The SMILES of NAB-14 was converted to a valid 3D Lewis structure using LigPrep (Schrödinger LLC, NY, USA) and was geometrically optimized with the OPLS4 force field81. The cryo-EM image of the heterotetrameric GluN1a/GluN2D NMDAR (PDB ID: 7YFF) structure was prepared for docking with the Protein PrepWizard82. This step involves adding missing hydrogen atoms and adjusting the ionization state of polar amino acids at neutral pH and, finally, energetically minimizing the structure using the OPLS4 force field. The geometric center of residue C590 (located on the GluN2D-TMD M1 helix) was considered the grid centroid, and flexible docking was carried out using Glide with the SP scoring function83.
Analysis of patch-clamp whole-cell data
Rs and Rm: Whole-cell currents in response to 50 ms/-5 mV hyperpolarizing pulses were analyzed. Rs was calculated by dividing -5 mV by the maximal current amplitude (Is). Rs represents the electrical resistance between the pipette and cell soma in whole-cell measurements. Rm was calculated by dividing -5 mV by the stable current amplitude (Im) after the initial current peak and represents the input resistance of the patched cell.
Analysis of LTP: In the LTP figures, each dot represents six consecutive averaged maximum EPSP amplitudes ± SEM. The horizontal bars at 25-30 min indicate the significant differences between baseline and postinduction EPSP amplitudes within each experimental group. The mean amplitude of 30 consecutive EPSPs was calculated before the induction protocol to obtain the baseline amplitude. Twenty-five minutes after LTP induction, the mean amplitude of 30 consecutive EPSPs was calculated and compared to the baseline value from the same experiment with a two-tailed t test. Changes in EPSP amplitudes are expressed as percentages of the baseline measurements and were analyzed for each experimental group to quantify the degree of LTP.
Paired-pulse ratio (PPR): In most experiments, every 10th EPSP was replaced by two consecutive EPSPs (EPSP 1/2) with an interval of 50 ms, and their maximal amplitudes were measured. The PPR was then calculated as (EPSP2 (mV))/(EPSP 1 (mV)), and the mean PPR values were compared between baseline values before induction of the weak aLTP and those 25-30 min after induction. A change in the PPR commonly indicates a change in the probability of presynaptic transmitter release, whereas no change indicates a postsynaptic mechanism84–86.
MICA-EPSP amplitude: The maximum EPSP amplitudes from min 0-10 were averaged and compared to the average maximum EPSP amplitudes from min 20-30.
MICA-AP-conversion: A 10-minute baseline was recorded during continuous MICA protocol stimulation at 0.2 Hz with EPSPs adjusted close to AP-threshold levels (ca. 15-25 mV). Thereafter, test substances were added to the bath solution, and recording continued for 20 minutes. AP spikes were counted and calculated as the mean number of APs over periods of 10 minutes.
MICA-Decay Tau: The trace of each EPSP was fitted using the following formula:
y(x) = RMP + Amp_1 * {1 - exp(-(x-t0_1)/Tau_on)} * exp(-(x-t0_1)/Tau_decay)
where RMP is the resting membrane potential (mV) and AMP_1 (mV) is the maximum EPSP amplitude. Tau_on (ms) is the onset tau of the EPSP, and Tau decay (ms) is the decay. For each cell, the mean EPSP-decay tau time constants were calculated and averaged for each experimental group. Fitmaster NEXT (HEKA, Germany) was used for fitting.
Fitting (Fig. 3): For the NMDAR current experiments and weak-aLTP experiments with NAB-14, a nonlinear regression was fitted to the measured x/y values, and the IC50 values were calculated (x = NMDAR current/amount of LTP, y = KET/NAB-14 concentration). The model used was as follows:
IC50 = ICF/(F/(100-F))^(1/Hill slope)
Y = Bottom + (Top-Bottom)/(1+(IC50/X)^HillSlope)
(F = 50)
For weak LTP experiments with KET, a Gaussian distribution model was fitted to the measured x/y values (x = amount of LTP, Y = KET concentration). The model used was as follows:
Y = Amplitude*exp(-0.5*((X-Mean)/SD)^2)
CV analysis: The slope of the EPSP rise at 20% to 40% of its maximal amplitude, at which point an approximately linear increase in its voltage could be assumed, was fitted with Fitmaster software (HEKA, Germany). We analyzed 20 EPSPs before and 20 EPSPs 25-30 min after NAB-14 wash-in in the MICA protocol for each experiment. The coefficient of variation (CV) is the standard deviation of the EPSP slopes divided by the mean. The inverse square of the CV of the postwash-in slopes was divided by the inverse square of the prewash-in slopes and plotted against the corresponding normalized slopes. Pre- and postwash-in measurements from a single experiment are connected by a line. In a standard quantal model for synaptic transmission, synaptic responses are affected either by presynaptic changes in the number of release sites and/or the probability of release or by modifications of the postsynaptic response to a single vehicle. A change in the ratio of CV-2 reflects a presynaptic action, whereas horizontal lines in the CV-2 plot indicate a change in postsynaptic responsiveness85,87,88.
Morphological analysis
All quantifications were performed by a blinded researcher. For GAD65 quantification, all images were normalized using the quantile-based normalization plugin Fiji (https://www.longair.net/edinburgh/imagej/quantile-normalization/). The intensity distribution of the images was normalized using 256 quantiles for each staining. The synaptic boutons were extracted from the background using the 3D Weka Segmentation plugin (https://imagej.net/Trainable_Weka_Segmentation) after manual selection of signal and background samples for training. The Fiji built-in plugin 3D object counter was then used to count and measure every object (cluster of GAD65-positive signal).
For VGLUT1 quantification, the raw images were first deconvoluted using Huygens software (Scientific Volume Imaging, The Netherlands). VGLUT1 density and volume were then quantified using built-in Spot detection analysis with Imaris 10.0 software (Oxford Instruments, United Kingdom).